Obesity leads to increased production of pro-inflammatory proteins like TNFα and IL-6 from adipose tissue and decreased levels of the anti-inflammatory protein adiponectin, resulting in insulin resistance. This insulin resistance causes fat breakdown in adipose tissue and release of free fatty acids into the liver through the portal vein, contributing to non-alcoholic fatty liver disease, increased blood sugar and fat levels, and damage to pancreatic beta cells.
Obesity leads to increased production of pro-inflammatory proteins like TNFα and IL-6 from adipose tissue and decreased levels of the anti-inflammatory protein adiponectin, resulting in insulin resistance. This insulin resistance causes fat breakdown in adipose tissue and release of free fatty acids into the liver through the portal vein, contributing to non-alcoholic fatty liver disease, increased blood sugar and fat levels, and damage to pancreatic beta cells.
Obesity leads to increased production of pro-inflammatory proteins like TNFα and IL-6 from adipose tissue and decreased levels of the anti-inflammatory protein adiponectin, resulting in insulin resistance. This insulin resistance causes fat breakdown in adipose tissue and release of free fatty acids into the liver through the portal vein, contributing to non-alcoholic fatty liver disease, increased blood sugar and fat levels, and damage to pancreatic beta cells.